Jun 12, 2019

Determining Risk of Recurrence in Triple-Negative Breast Cancer

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah.

May 29, 2019

Art Meets Science

Bryan Welm, PhD, has found a unique way to merge his love for science and art.

Mar 01, 2019

Together We Care Compassionately

Approximately 500 patients visit the outpatient clinics and infusion center at Huntsman Cancer Institute each day. Our patients rely on our clinical teams and staff to provide safe, efficient, and high quality care during each clinic visit. In this letter from Don Milligan, director of outpatient services, highlights recent efforts to provide the best care possible.

Feb 04, 2019

New Study Shows Cost Effectiveness of Early Cancer Surveillance for Patients Who Have a High Risk of Developing Cancer

New research published today in the journal Pediatric Blood and Cancer shows how early cancer screening and surveillance in patients with Li-Fraumeni Syndrome (LFS) results in additional years of life, and is cost effective for third-party payers.

Oct 16, 2018

A Bad Influence: The Interplay between Tumor Cells and Immune Cells

Research at Huntsman Cancer Institute at the University of Utah yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment. The results were published today in Immunity and featured on the print cover of the journal.

Oct 04, 2018

Talks with Docs: Cindy Matsen, MD

At Huntsman Cancer Institute, Dr. Cindy Matsen helps provide patients with surgical options as they undergo treatment for their breast cancer. In this interview, we learn about the relationships she builds with her female patients and what they teach her every day.

Aug 10, 2018

Nurturing Future Cancer Researchers in the PathMaker Program

The PathMaker program is a stepping stone for students interested in a career in health sciences or STEM with backgrounds underrepresented in the biomedical workforce.

Jul 13, 2018

Huntsman Cancer Institute Names Cornelia Ulrich as Director of its Cancer Research Center

Huntsman Cancer Institute at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment.

Jun 11, 2018

Letter of Hope from the Gertz Lab

It is patients like you, your loved ones, and Dr. Gertz's parents who keep us motivated and excited to find ways to help in the fight against this terrible disease. We appreciate everything you do as patients—like donating samples and participating in clinical trials—and we want you to know that we are doing everything we can to help patients with breast and uterine cancer.

May 18, 2018

Space Could Be the New Frontier for Cancer Research

On May 16, 2018, HCI hosted a NASA astronaut and a team from the Center for the Advancement of Science in Space to discuss the opportunity of researching cancer in space.

Mar 13, 2018

Surprising Discovery Provides Insights into Aggressive Endometrial Cancers

New research from Huntsman Cancer Institute at the University of Utah indicates steroid and hormone receptors are simultaneously active in many endometrial cancer tissues. The findings, published today in the journal Cell Reports, yield insights about factors that contribute to more aggressive endometrial tumors.

Feb 27, 2018

New understanding of enzyme’s role in development of certain brain and spinal cord tumors

In a study recently published in Acta Neuropathologica, L. Eric Huang, MD, PhD, Huntsman Cancer Institute researcher and associate professor of neurosurgery at the University of Utah, and colleagues report on new findings in the function of an enzyme, IDH1, in the development of gliomas. Gliomas are life-threatening tumors of brain or spinal cord tissue, and this type of tumor affects approximately 25,000 people each year. As changes in IDH1 are found in the vast majority of gliomas, understanding the impact of IDH1 enzyme function is critical to advancing research in this disease.

Feb 15, 2018

Developing Better Targeted Therapies

Targeted therapy in cancer treatment is often called personalized or precision medicine, according to the National Institutes of Health. Targeted therapies are designed to be more effective and less harmful than other approaches because the drugs are specially designed to meet the individual characteristics of each patient.

Feb 15, 2018

Message from HCI's CEO

The West is known for its "can-do" spirit, for the willingness of people to work together. At Huntsman Cancer Institute, we strive to push the boundaries of cancer research and care and attain results beyond what we thought was possible. We've made a commitment to advance cutting-edge cancer research and care in the Mountain West region.

Feb 15, 2018

Working in Harmony: New Insights into How Packages of DNA Orchestrate Development

New research from Huntsman Cancer Institute at the University of Utah illuminates aspects of how an early embryo, the product of fertilization of a female egg cell by a male sperm cell, can give rise to all the many cell types of the adult animal. The findings, published in the journal Cell, have significant implications for understanding how early development is orchestrated, and provides a mechanism for how parental environment might impact the expression of these genes in the offspring.

Feb 15, 2018

Training the Next Generation of Cancer Researchers

Over the years, there have been many landmark discoveries in the effort to eradicate cancer. Progress can only continue with well-trained and passionate researchers and physicians. Huntsman Cancer Institute faculty work with students of all ages to cultivate the next generation of scientists who will carry on this life-saving work.

Oct 25, 2017

Huntsman Cancer Institute’s Researchers Develop New Method for Gene Silencing

A study published today in Cell Systems highlights a new research method using the recently developed CRISPR technique. In short, CRISPR is a technology that allows researchers to cut out a section of DNA that causes a disease, like cancer, and then replace the section with normal, healthy genes.

Oct 05, 2017

New Research on Sperm Stem Cells has Implications for Male Infertility and Cancer

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah and collaborators at University of Utah Health (U of U Health) sheds light on the complex process that occurs in the development of human sperm stem cells. This is the first study to characterize the changes human sperm stem cells undergo as they mature. The results have implications for understanding male infertility as well as cancer development and were published today in the journal Cell Stem Cell.

Jun 09, 2017

New Cancer Drug Tested In Mice May Benefit Certain Leukemia Patients

SALT LAKE CITY –Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults. Scientists have found up to 30 percent of adult ALL patients have what’s called a Philadelphia chromosome, where two segments of chromosomes have aberrantly fused together. (The fusion chromosome is much less common in children.) Adult ALL patients exposed to standard treatments often see high relapse rates, and treatment-related deaths remain high. But researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered new science, published this week in the journal Leukemia, that could provide better therapeutic options for patients.

Apr 12, 2017

Huntsman Cancer Institute Investigators Elected to American Academy of Arts and Sciences

University of Utah professors Bradley R. Cairns, professor and chair of Oncological Sciences and senior director of Basic Science at Huntsman Cancer Institute; Dana Carroll, distinguished professor of Biochemistry and HCI investigator; and Christopher D. Hacon, distinguished professor of Mathematics, were raised to a high honor in science today with their election to the American Academy of Arts and Sciences.

Apr 11, 2017

Huntsman Cancer Institute Researchers Share Expertise at National Cancer Meeting

More than 20 researchers from Huntsman Cancer Institute (HCI) at the University of Utah made their mark on the American Association of Cancer Research (AACR) Annual Meeting this year. Held in Washington, D.C., the convention drew more than 21,500 cancer researchers from all over the world. Scientists attended sessions on topics from immunotherapy to precision medicine. About 15 researchers from HCI presented posters in the main conference hall, on a wide range of topics.

Jan 01, 2017

HCI CEO and Director Serves as Panelist at White House Event

Mary Beckerle, PhD, CEO of Huntsman Cancer Institute, served as a panelist at an event organized by the White House Cancer Moonshot Task Force. Beckerle participated in a discussion on addressing disparities in access to cancer prevention, diagnosis, and treatment.

Sep 08, 2016

Putting an End to a Deadly Family Mystery

When Kiera Jorgensen was diagnosed with cancer at the age of 19, she fought not only sarcoma, but also a deadly mystery that had loomed over her family for generations. Now years out of treatment, Kiera has answers and is conducting research to help families like hers better understand a rare genetic mutation.

Jun 09, 2016

Letter of Hope from the Varley Lab

You might not see us during your visit to Huntsman Cancer Institute, but we want to let you know that we are working hard in the Varley Lab in the HCI research building next door. We conduct research that improves the treatment and care of patients like you. We are a small group of dedicated young men and women who are developing new strategies to diagnose and treat breast and ovarian cancer.

Apr 11, 2016

Giving Someone a One-in-a-Million Chance at Life

Bone marrow transplant patients at Huntsman Cancer Institute know all too well the importance of finding a donor who is a match. Maggie Kasten, a bone marrow donor and a research scientist in the Cairns Lab at HCI, also understands.

Apr 13, 2015

Characterization of the Nutrient Needs of Triple Negative Breast Cancer Leads to the Identification of a Molecular Signature for Cancer Outcomes

Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. In a new study published in the journal Proceedings of the National Academy of Sciences (PNAS), researchers at Huntsman Cancer Institute and the University of Utah have identified a molecular mechanism that triple negative breast cancer cells use to survive and grow.